Doctor profile · Federal record
Dr. Bryan Bienvenu, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Baton Rouge, LA
- NPI 1932121795
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 31 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4950 Essen Lane
Baton Rouge, LA 708093482
(225) 767-1311
fax (225) 766-0218 - Additional location
-
5439 Airline Hwy
Baton Rouge, LA 708051712
(225) 358-2313
fax (225) 358-2322
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 13, 2021
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Louisiana #22546
- Medicaid
- LA #1490351
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932121795. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
48,688
Distinct HCPCS
10
Medicare allowed
$1,222,142
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 17,250 | 11 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,800 | 12 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,150 | 20 | $0 | |
Q5123 |
Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 2,440 | 12 | $44 | |
J0897 |
Injection, denosumab, 1 mg | 2,160 | 16 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,758 | 49 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 992 | 29 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 865 | 318 | $118 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 540 | 29 | $1 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 484 | 172 | $165 |
In context: peer comparison
Among 13 peers in Baton Rouge Hematology & Oncology Physician, average services per provider: 1,050. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$482
Transactions
24
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 4 | $91.48 | |
| Abbvie INC. | 4 | $87.89 | |
| Daiichi Sankyo INC. | 3 | $71.77 | |
| Celgene Corporation | 4 | $67.74 | |
| Exelixis INC. | 2 | $41.96 | |
| Janssen Biotech, INC. | 2 | $36.96 | |
| Tempus Ai, INC | 1 | $23.31 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $16.11 | |
| BeiGene USA, INC. | 1 | $15.94 | |
| Taiho Oncology, INC. | 1 | $15.91 | |
| Array Biopharma INC | 1 | $13.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,429
Patients
553
Total drug cost
$50,444
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 625 | 122 | $6,422 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 313 | 79 | $12,250 |
| Oxycodone Hcl | Generic | 199 | 34 | $11,252 |
| Gabapentin | Generic | 162 | 33 | $3,493 |
| Pantoprazole Sodium | Generic | 160 | 44 | $1,909 |
| Prednisone | Generic | 120 | 39 | $970 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 119 | 18 | $4,870 |
| Ondansetron Hcl | Generic | 100 | 33 | $906 |
| Alprazolam | Generic | 97 | 22 | $629 |
| Temazepam | Generic | 94 | 21 | $929 |
Hospital affiliations
Frequently asked questions
What is Dr. Bryan Bienvenu's medical specialty?
Dr. Bryan Bienvenu practices Hematology & Oncology Physician in Baton Rouge, LA.
Where does Dr. Bryan Bienvenu practice?
Dr. Bryan Bienvenu practices at 4950 Essen Lane, Baton Rouge, LA 708093482. Office phone: 2257671311.
What is Dr. Bryan Bienvenu's NPI?
Dr. Bryan Bienvenu's National Provider Identifier (NPI) is 1932121795, issued by NPPES.
Does Dr. Bryan Bienvenu accept Medicare assignment?
Yes. Dr. Bryan Bienvenu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Bryan Bienvenu commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.